Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Discover a one-step Pd-catalyzed synthesis of 1,5-dihydro-2H-pyrrole-2-ketone with 70-92% yield. Eliminate multi-step processes and supply chain risks for API intermediates.
Solve low-yield C-H activation challenges with 94% yield & 92% ee. Scale to 100MT/yr with no byproducts. Contact for COA/MSDS.
Discover how this novel palladium-catalyzed route to 3-arylquinoline-2(1H) ketone derivatives reduces production costs by 30% while maintaining >99% purity for API manufacturing.
Eliminate azide hazards and anhydrous conditions in triazole synthesis. Our CDMO expertise delivers high-yield, scalable production for API intermediates with 99%+ purity.
Solve low-yield 1,2,4-triazol-3-one synthesis with this Pd-catalyzed method. Achieve 99% purity, scalable production, and cost savings for drug development. Contact us for custom synthesis.
Discover a scalable, low-cost route for pyrrolo[3,2-c]quinoline synthesis with broad substrate tolerance. Reduce R&D costs and supply chain risks for pharmaceutical intermediates.
Discover a catalyst-free pyrazole synthesis method with 47-92% yield. Reduce production costs and supply chain risks for pharmaceutical intermediates and agrochemicals.
Discover a breakthrough gold-catalyzed method for indole-3-phosphonate synthesis with 90%+ yields, mild conditions, and easy catalyst separation. Ideal for pharma R&D and production scaling.
Discover how this novel chiral pyrrole synthesis method achieves 96% ee and 92% yield with room-temperature operation, reducing your API production costs by 30% while meeting ICH Q7 standards.
Solve low yield and impurity issues in camptothecin synthesis. New deprotection method cuts solvent use, boosts purity to 99.9% and recovers mother liquor for cost savings.
Discover a scalable, cost-effective synthesis method for indolocyclopentane compounds with >95% yield and 93% ee. Ideal for pharmaceutical R&D and production of prostate cancer therapeutics.
Solve supply chain risks with air-stable, metal-free synthesis of trifluoroacetimide dihydrobenzofuran. High stereoselectivity & scalable to 100MT/yr. Contact for COA/MSDS.
Discover how palladium-catalyzed 3-arylquinoline-2(1H) ketone synthesis with broad functional group tolerance reduces production costs and supply chain risks for pharmaceutical intermediates.
Skip Boc protection steps and cut 15% production costs with this 5-step Taladegib route. Our CDMO expertise ensures >99% purity and scalable manufacturing.
Solve high-cost Boc protection in Taladegib synthesis. Our CDMO expertise delivers 92% yield with 5-step route, ensuring GMP compliance and supply chain stability.
Discover a 99% yield, room-temperature synthesis of indole-pyrrole tetraarylmethanes for HepG2 cytotoxicity. Reduce costs and scale production with our CDMO expertise.
Discover how this novel bromine-free route eliminates unstable reagents, reduces production costs, and ensures consistent supply for your bronchodilator manufacturing.
Solve high-cost, low-yield issues in chiral indolooxa synthesis. This patent reveals a mild, scalable method with 90% yield & 92% ee for Hela cancer cell activity. Optimize your API supply chain now.
Solve supply chain risks with a novel quinazoline synthesis method. Achieve 99%+ purity and 90%+ yield without noble metals. Ideal for API production.
Solve enantioselectivity challenges in asymmetric hydrogenation with tunable bisphosphine ligands. Achieve 92-99% ee, recyclable catalysts, and simplified synthesis for cost-effective API production.